Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;27(Suppl 1):43S–45S. doi: 10.1111/j.1365-2125.1989.tb03460.x

Neuropathology of vigabatrin

D Graham
PMCID: PMC1379678  PMID: 2757908

Abstract

1 Neuropathological changes in experimental animals have been observed with vigabatrin treatment in mice, rats and dogs.

2 These changes have comprised intramyelinic oedema which is reversible on cessation of treatment.

3 In human studies so far, no intramyelinic oedema has been noted. It is not clear whether humans will show the neurotoxicity observed in animals; close monitoring of patients is indicated.

Keywords: vigabatrin, neuropathology, intra-myelinic oedema

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aleu F. P., Katzman R., Terry R. D. Fine structure and electrolyte analyses of cerebral edema induced by alkyl tin intoxication. J Neuropathol Exp Neurol. 1963 Jul;22(3):403–413. doi: 10.1097/00005072-196307000-00003. [DOI] [PubMed] [Google Scholar]
  2. Butler W. H., Ford G. P., Newberne J. W. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicol Pathol. 1987;15(2):143–148. doi: 10.1177/019262338701500203. [DOI] [PubMed] [Google Scholar]
  3. Carlton W. W., Kreutzberg G. Isonicotinic acid hydrazide-induced spongy degeneration of the white matter in the brains of Pekin ducks. Am J Pathol. 1966 Jan;48(1):91–105. [PMC free article] [PubMed] [Google Scholar]
  4. Towfighi J., Gonatas N. K., McCree L. Hexachlorophene neuropathy in rats. Lab Invest. 1973 Oct;29(4):428–436. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES